NO984524D0 - Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer - Google Patents

Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer

Info

Publication number
NO984524D0
NO984524D0 NO984524A NO984524A NO984524D0 NO 984524 D0 NO984524 D0 NO 984524D0 NO 984524 A NO984524 A NO 984524A NO 984524 A NO984524 A NO 984524A NO 984524 D0 NO984524 D0 NO 984524D0
Authority
NO
Norway
Prior art keywords
cholesterol
uptake inhibitors
amphipathic molecules
lipid uptake
lipid
Prior art date
Application number
NO984524A
Other languages
English (en)
Other versions
NO984524L (no
Inventor
Dario Boffelli
Helmut Hauser
Original Assignee
Dario Boffelli
Helmut Hauser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606686.5A external-priority patent/GB9606686D0/en
Priority claimed from GBGB9626920.4A external-priority patent/GB9626920D0/en
Application filed by Dario Boffelli, Helmut Hauser filed Critical Dario Boffelli
Publication of NO984524D0 publication Critical patent/NO984524D0/no
Publication of NO984524L publication Critical patent/NO984524L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO984524A 1996-03-29 1998-09-28 Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer NO984524L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606686.5A GB9606686D0 (en) 1996-03-29 1996-03-29 Medical use
GBGB9626920.4A GB9626920D0 (en) 1996-12-24 1996-12-24 Medical use
PCT/IB1997/000379 WO1997036927A1 (en) 1996-03-29 1997-03-27 Amphipathic molecules as cholesterol and other lipid uptake inhibitors

Publications (2)

Publication Number Publication Date
NO984524D0 true NO984524D0 (no) 1998-09-28
NO984524L NO984524L (no) 1998-11-30

Family

ID=26309021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984524A NO984524L (no) 1996-03-29 1998-09-28 Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer

Country Status (9)

Country Link
US (1) US20010005714A1 (no)
EP (1) EP0889906A1 (no)
JP (1) JP2000509020A (no)
CN (1) CN1109047C (no)
AU (1) AU710061B2 (no)
CA (1) CA2249459A1 (no)
NO (1) NO984524L (no)
NZ (1) NZ331980A (no)
WO (1) WO1997036927A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046166A (en) 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) * 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
EP1090634A1 (en) * 1999-10-01 2001-04-11 Helmut Hauser Agents for reducing cholesterol and lipid uptake
US7250304B2 (en) 2000-03-31 2007-07-31 The Regents Of The University Of California Functional assay of high-density lipoprotein
AU2007237157B2 (en) * 2000-08-24 2009-04-09 The Regents Of The University Of California Peptides that ameliorate atherosclerosis
US7148197B2 (en) 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US7144862B2 (en) 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7166578B2 (en) 2000-08-24 2007-01-23 The Regents Of The University Of California Orally administered peptides synergize statin activity
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7199102B2 (en) * 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7723303B2 (en) 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
CN100594933C (zh) * 2000-11-28 2010-03-24 田边三菱制药株式会社 抗肥胖剂和健康食品
US6930085B2 (en) 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
CA2486127C (en) 2002-05-17 2014-03-11 Esperion Therapeutics, Inc. Method of treating dyslipidemic disorders
NZ541504A (en) * 2002-11-13 2009-04-30 Uab Research Foundation Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use
DE10343815A1 (de) * 2003-09-22 2005-04-14 B.R.A.H.M.S Ag Verfahren zur Diagnose von Erkrankungen unter Bestimmung von Apolipoprotein C-I, und dessen Verwendung in der Therapie von Erkrankungen
EP1799242A4 (en) * 2004-09-16 2009-11-11 Univ California TYPE G PEPTIDES AND OTHER ACTIVE SUBSTANCES TO REDUCE ATHEROSCLEROSIS AND OTHER DISEASES
CA2595067A1 (en) 2004-12-06 2006-06-15 The Regents Of The University Of California Methods for improving the structure and function of arterioles
US20080293639A1 (en) * 2005-04-29 2008-11-27 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
EP2368561B1 (en) * 2005-04-29 2013-12-04 The Regents of The University of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
WO2007000924A1 (ja) * 2005-06-28 2007-01-04 Osaka University プログラニュリン活性を抑制または促進する物質を含む医薬組成物、およびプログラニュリン活性を抑制または促進する物質のスクリーニング方法
EP1836906B1 (en) * 2006-03-24 2009-07-01 Unilever N.V. Healthy food product
WO2007110297A1 (en) * 2006-03-24 2007-10-04 Unilever N.V. Healthy food product
AU2007229603A1 (en) * 2006-03-24 2007-10-04 Unilever Plc Healthy food product
AU2007284801A1 (en) 2006-08-08 2008-02-21 The Regents Of The University Of Californina Salicylanilides enhance oral delivery of therapeutic peptides
DK2682400T5 (da) 2007-08-28 2017-11-27 Uab Research Foundation Syntetiske apolipoprotein E-efterlignende polypeptider og fremgangsmåder til anvendelse
US8557767B2 (en) 2007-08-28 2013-10-15 Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
US8044021B2 (en) 2007-09-20 2011-10-25 Abbott Cardiovascular Systems Inc. Sustained release of apo A-I mimetic peptides and methods of treatment
US7985728B1 (en) 2007-09-20 2011-07-26 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
US8101565B2 (en) * 2007-09-20 2012-01-24 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
US9173890B2 (en) 2007-09-20 2015-11-03 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
US7985727B1 (en) 2007-09-20 2011-07-26 Abbott Cardiovascular Systems Inc. Apo A-I mimetic peptides and methods of treatment
AU2015298263B2 (en) 2014-07-31 2020-05-14 Anji Pharmaceuticals, Inc. ApoE mimetic peptides and higher potency to clear plasma cholesterol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007930A1 (en) * 1993-09-15 1995-03-23 Cv Therapeutics, Inc. Protein for mediating cholesterol absorption and an inhibitor thereof
US5373009A (en) * 1994-02-02 1994-12-13 American Home Products Corporation Dibenzofuranyl esters of N-heterocyclic carboxylic acids

Also Published As

Publication number Publication date
AU710061B2 (en) 1999-09-09
US20010005714A1 (en) 2001-06-28
EP0889906A1 (en) 1999-01-13
JP2000509020A (ja) 2000-07-18
NO984524L (no) 1998-11-30
NZ331980A (en) 2000-09-29
CN1216995A (zh) 1999-05-19
CN1109047C (zh) 2003-05-21
CA2249459A1 (en) 1997-10-09
WO1997036927A1 (en) 1997-10-09
AU2174197A (en) 1997-10-22

Similar Documents

Publication Publication Date Title
NO984524D0 (no) Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer
DK0900225T3 (da) Alkyl-4-silyl-phenoler og estere deraf som antiatherosklerosemidler
DE69738510D1 (de) Plasmaanzeigeeinrichtung in Unterrahmenmodus
DK0925303T3 (da) Phosphinsyreamider som matrixmetalloproteaseinhibitorer
NO20020197L (no) Renseapparat og fremgangsmåte som utnytter en siloksanblanding som et lösemiddel
DK0944590T3 (da) Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer
NO992725D0 (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
DK0934259T3 (da) Beta-sulfonamidohydroxamsyrer som matrixmetalloproteinase- og TACE-inhibitorer
PT956294E (pt) Inibidores da trombina
ATE229318T1 (de) Entferner für keratöse komedonen
FI982291A0 (fi) Aine kolesterolin sekä lipidien pitoisuuden alentamiseksi
NO991770L (no) Bµrere som inneholder et eterlipid/komplementµr formlipidkombinasjon og terapeutisk bruk derav
FI970499A (fi) Menetelmä ja aine lipidien absorption vähentämiseksi
ATE240714T1 (de) Entferner für keratöse komedonen
DE69731574D1 (de) Kompiliergerät und -verfahren
BR9507992A (pt) Esteres do ácido 4-carbamoilóxi-piperdino-1-carboxílico inibidores da absorção de colesterol
KR950024444U (ko) 판촉용 티슈 팩
KR970000223A (ko) 콜레스테롤 생합성 저해제
DE29702396U1 (de) Montageständer für Inline-Skater
BR7400264U (pt) Painel iluminado para mensagem promocional
BR9404556A (pt) Expositor para aplicaçao geral
BR7400858U (pt) Expositor para brincos
BR7400219U (pt) Painel original para exposição de medalhas
DE29501740U1 (de) Fahnenstange und Verbindungsstück dazu
BR9701430A (pt) Disposição construtiva introduzida em painel para publicidade

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application